Sodium Picosulfate: A Key Intermediate in Pharmaceutical Formulations
In the complex landscape of pharmaceutical development and manufacturing, the identification and sourcing of key intermediates are pivotal for creating effective and safe medicinal products. Sodium Picosulfate, identified by CAS number 10040-45-6, holds a significant position as a crucial intermediate and active ingredient, primarily recognized for its potent stimulant laxative properties. Its distinct chemical characteristics and pharmacological actions make it an indispensable component in a range of therapeutic formulations.
The utility of Sodium Picosulfate is most prominently observed in its application within gastrointestinal medications. As a stimulant laxative, it plays a vital role in the symptomatic treatment of constipation. Its mechanism involves direct stimulation of the intestinal mucosa, leading to enhanced peristalsis and facilitating bowel movement. Furthermore, its formulation in various bowel preparation solutions for procedures like colonoscopies underscores its importance in diagnostic healthcare, ensuring optimal visual access for clinicians.
For pharmaceutical manufacturers, the procurement of Sodium Picosulfate requires meticulous attention to quality and purity. The compound, typically supplied as a white crystalline powder, must meet stringent specifications to ensure its efficacy and safety in human use. This includes a high degree of chemical purity, consistent physical properties, and adherence to relevant pharmaceutical standards. Therefore, selecting a reliable Sodium Picosulfate manufacturer and supplier is a critical decision in the drug development and production lifecycle.
When seeking to purchase Sodium Picosulfate, especially in large or bulk quantities, manufacturers often look to specialized chemical companies that can guarantee consistent quality and supply chain reliability. Factors such as lot-to-lot consistency, comprehensive documentation (including Certificates of Analysis), and compliance with international regulatory requirements are paramount. The ability of a supplier to provide these assurances directly impacts the manufacturer's ability to meet their own production timelines and quality mandates.
The global market for pharmaceutical intermediates is dynamic, with many specialized manufacturers located in regions like China, offering competitive pricing and significant production capacities. Engaging with these suppliers can provide cost advantages without compromising on the quality required for pharmaceutical applications. If your organization is involved in the formulation of laxatives, bowel preparation agents, or other gastrointestinal therapies, securing a dependable source of Sodium Picosulfate (CAS 10040-45-6) is essential for success. We invite you to contact us to discuss your needs for this vital pharmaceutical intermediate and to obtain a competitive quote for your bulk purchase requirements.
Perspectives & Insights
Core Pioneer 24
“If your organization is involved in the formulation of laxatives, bowel preparation agents, or other gastrointestinal therapies, securing a dependable source of Sodium Picosulfate (CAS 10040-45-6) is essential for success.”
Silicon Explorer X
“We invite you to contact us to discuss your needs for this vital pharmaceutical intermediate and to obtain a competitive quote for your bulk purchase requirements.”
Quantum Catalyst AI
“In the complex landscape of pharmaceutical development and manufacturing, the identification and sourcing of key intermediates are pivotal for creating effective and safe medicinal products.”